coagulation factor VII
Última atualização 18 de ago de 2020
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Ask Patient
- Versão em Áudio
- Adicionar às fontes preferidas no Google
A F7 gene provides instructions for making a protein called coagulation factor VII. Coagulation factors are a group of related proteins that are involved in the coagulation system, which is a series of chemical reactions that form blood clots. After an injury, clots seal off blood vessels to stop bleeding and trigger blood vessel repair.
Escolhas de vídeos para GenesBiblioteca de vídeos
Normal function
A F7 gene provides instructions for making a protein called coagulation factor VII. Coagulation factors are a group of related proteins that are involved in the coagulation system, which is a series of chemical reactions that form blood clots. After an injury, clots seal off blood vessels to stop bleeding and trigger blood vessel repair.
Coagulation factor VII is made primarily by cells in the liver. The protein circulates in the bloodstream in an inactive form until the coagulation system is turned on (activated) by an injury that damages blood vessels. Activated coagulation factor VII helps turn on other coagulation factors in turn. This step-wise process ultimately promotes the conversion of an important coagulation protein called fibrinogen into fibrin, which is the material that forms blood clots.
Conditions referring to this gene or chromosome
Other names
FVII coagulation protein
proconvertin
serum prothrombin conversion accelerator
SPCA
Related patient information and medicines

Patient information leaflet
Trombofilia
It can lead to venous blood clots, often in unusual sites such as the veins of the gut, liver or... Anticoagulation may be needed and there are other treatments too for this condition. Elevated factor VIII This is pronounced 'factor 8'. It is due to abnormally high levels of factor VIII, which is one of the blood chemicals that promotes clotting..

Patient information leaflet
Testes de coagulação do sangue
Testes de coagulação do sangue are used to diagnose e assess bleeding problems and to monitor people who take warfarin or other anticoagulant medicines. One or more of these tests may be done if a gene... For example, the amount of factor VIII can be measured in a blood sample. (The level is very low or absent in people with haemophilia A.) Platelet.

Patient information leaflet
Hemofilia
Hemofilia é a rare bleeding disorder that affects your ability to make a clot. The blood contains substances called clotting factors that work with platelets to form a clot. When you injure yourself the clot stops you bleeding... A newer treatment has been developed that does not directly replace the clotting factor. It is a monoclonal antibody.

Patient information leaflet
Esofago de Barrett
Barrett'. It typically affects people between the ages of 50 and 70 years. The coil then emits heat ene... Nearby normal cells then multiply and replace the destroyed abnormal cells. Argon plasma coagulation This treatment uses a jet of argon gas, together with an electric current, to burn away dysplastic cells. Endoscopic mucosal resection (EMR).

Patient information leaflet
Pré-eclâmpsia
Complications Most women with pre-eclampsia or HE... The risk of complications increases the more severe the pre-eclampsia becomes. The risk of complications is reduced if pre-eclampsia is diagnosed early and treated. A rare mas serious complication é disseminated intravascular coagulation, which can occur if a woman has had to have many blood.

Patient information leaflet
Hemorroidas
The piles then die and drop off, similar to after banding. Coagulação/Foto-coagulação por Infravermelho This method of piles treatment uses infrared light to burn and cut off the circulation to the haemorrhoid, which causes it to shrink in size. It may be as effective as banding treatment and injection sclerotherapy for first- and second-degree piles..
Leitura adicional e referências
- coagulation factor VII; MedlinePlus, National Library of Medicine.
- Girolami A, Cosi E, Santarossa C, Ferrari S, Luigia Randi M. The Story of Serum Prothrombin Conversion Accelerator, Proconvertin, Stable Factor, Cothromboplastin, Prothrombin Accelerator or Autoprothrombin I, and Their Subsequent Merging into Factor VII. Semin Thromb Hemost. 2015 Jun;41(4):366-73. doi: 10.1055/s-0035-1549851. Epub 2015 May 14.
- Herrmann FH, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, Kreuz W, Pollmann H, Ruiz-Saez A, De Bosch N, Salazar-Sanchez L; Greifswald Factor FVII Deficiency Study Group. Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia. 2009 Jan;15(1):267-80. doi: 10.1111/j.1365-2516.2008.01910.x. Epub 2008 Oct 30.
- Mariani G, Bernardi F. Factor VII Deficiency. Semin Thromb Hemost. 2009 Jun;35(4):400-6. doi: 10.1055/s-0029-1225762. Epub 2009 Jul 13.
- Mariani G, Herrmann FH, Bernardi F, Schved JF, Auerswald G, Ingerslev J. Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7). Blood. 2000 Jul 1;96(1):374. No abstract available.
- Mariani G, Herrmann FH, Dolce A, Batorova A, Etro D, Peyvandi F, Wulff K, Schved JF, Auerswald G, Ingerslev J, Bernardi F; International Factor VII Deficiency Study Group. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost. 2005 Mar;93(3):481-7. doi: 10.1160/TH04-10-0650.
Compartilhe seus pensamentos ou experiências com outros em nosso comunidades de pacientes.
Inscreva-se no boletim informativo do Patient
Sua dose semanal de conselhos de saúde claros e confiáveis - escritos para ajudá-lo a se sentir informado, confiante e no controle.
Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.

